Skip to main content
. Author manuscript; available in PMC: 2012 Oct 19.
Published in final edited form as: Arch Gen Psychiatry. 2011 Feb;68(2):128–137. doi: 10.1001/archgenpsychiatry.2010.199

Table 1.

APS Treatment Before Initial MRI Scan and Interval Preceding Each Follow-up Scan

Initial Scan (N=211) 1st Follow-up (n=211) 2nd Follow-up (n=139) 3rd Follow-up (n=82) 4th Follow-up (n=31)
Interscan interval, mean (SD), Ya NA 3.07 (1.57) 3.31 (0.92) 3.89 (1.21) 3.00 (0.36)
No treatment, No. (%) 31(14.7) 8 (3.8) 8 (5.8) 6 (7.3) 2 (6.5)
Clozapine treatment, No. (%) 15(7.1) 37 (17.5) 34 (24.5) 23(28.0) 10 (32.3)
APS dose, mean (SD), CPZ mg equivalents/d 245.3 (350.9) 348.9 (323.3) 438.9 (333.6) 519.9(320.5) 579.9 (336.3)
Type of APS treatment, mean (SD) % of total CPZ dose-yearsb
 Typical APSs 58.2 (45.6) 31.9 (39.3) 19.3(30.4) 16.4(30.0) 16.5 (31.7)
 Nonclozapine atypical APSs 38.8(46.1) 57.4 (41.7) 62.2(40.6) 60.9 (43.2) 60.7 (44.9)
 Clozapine 3.0(13.7) 10.7(26.9) 18.5(36.0) 22.7(39.3) 22.8 (39.0)

Abbreviations: APS, antipsychotic; CPZ, chlorpromazine; MRI, magnetic resonance imaging; NA, not applicable.

a

First follow-up is the time interval between the initial and first follow-up images; second follow-up, the time interval between the first and second follow-up images; etc.

b

One CPZ dose-year=100 mg of CPZ per day for 1 year.